We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fox Corp. (FOXA) to Report Q3 Earnings: What's in the Cards?
Read MoreHide Full Article
Fox Corporation (FOXA - Free Report) is set to report third-quarter fiscal 2021 results on May 5.
The Zacks Consensus Estimate for earnings has increased 5.5% to 58 cents per share over the past 30 days, indicating decline of 37.6% from the year-ago quarter.
The consensus mark for revenues is currently pegged at $3.1 billion, suggesting 9.9% decrease from the figure reported in the year-ago quarter.
Notably, Fox has a stellar surprise history. It beat estimates in each of the trailing four quarters, delivering an average surprise of 80.4%.
Coronavirus-induced lower but recovering ad demand and spending are expected to have impacted Fox’s fiscal third-quarter advertising revenues, which accounts for over 50% of the company’s top line.
Nonetheless, improved political-ad spending and resumption of certain sports events in the to-be-reported quarter are expected to have partially offset dented ad revenues due to postponement of sporting events globally.
Fox’s portfolio strength across entertainment, sports and news content is expected to drive the company’s third-quarter fiscal 2021 results. The company’s strong offerings are driving user growth and this trend is likely to have continued in the to-be-reported quarter.
Moreover, Fox’s investments in expanding its network are aiding ratings growth, a trend which is likely to have continued in the to-be-reported quarter.
In fact, in the to-be-reported quarter, FOX News Channel (FNC) finished the month of February as the top-rated network in all of cable in primetime, according to Nielsen Media Research and remained the top-rated network in all of cable in primetime total viewers since inauguration.
In total day viewership, FNC delivered 1.3 million viewers for the month of February, 210K in the 25-54 age group, and 119K in the 18-49 age group, outpacing sports-focused ESPN in both dayparts with total viewership.
Further, FOX News Audio added five new podcasts to its programming catalogue, debuting each week from Mar 8.
This is expected to have helped the company reach a global audience and expand its international user base while attracting advertisers to the OTT platform, thereby generating ad revenues.
Key Development in Q3
On Mar 18, Fox Corporation announced a new and expanded media rights agreement with the National Football League (NFL) for the next 11 years through the 2033 season.
What Our Model Says
According to the Zacks model, the combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.
Fox has an Earnings ESP of +13.40% and a Zacks Rank #1. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks to Consider
Here are a few more companies you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat in their upcoming releases:
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank #2.
AMETEK (AME - Free Report) has an Earnings ESP of +0.49% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Shutterstock
Fox Corp. (FOXA) to Report Q3 Earnings: What's in the Cards?
Fox Corporation (FOXA - Free Report) is set to report third-quarter fiscal 2021 results on May 5.
The Zacks Consensus Estimate for earnings has increased 5.5% to 58 cents per share over the past 30 days, indicating decline of 37.6% from the year-ago quarter.
The consensus mark for revenues is currently pegged at $3.1 billion, suggesting 9.9% decrease from the figure reported in the year-ago quarter.
Notably, Fox has a stellar surprise history. It beat estimates in each of the trailing four quarters, delivering an average surprise of 80.4%.
Fox Corporation Price and EPS Surprise
Fox Corporation price-eps-surprise | Fox Corporation Quote
Factors to Consider
Coronavirus-induced lower but recovering ad demand and spending are expected to have impacted Fox’s fiscal third-quarter advertising revenues, which accounts for over 50% of the company’s top line.
Nonetheless, improved political-ad spending and resumption of certain sports events in the to-be-reported quarter are expected to have partially offset dented ad revenues due to postponement of sporting events globally.
Fox’s portfolio strength across entertainment, sports and news content is expected to drive the company’s third-quarter fiscal 2021 results. The company’s strong offerings are driving user growth and this trend is likely to have continued in the to-be-reported quarter.
Moreover, Fox’s investments in expanding its network are aiding ratings growth, a trend which is likely to have continued in the to-be-reported quarter.
In fact, in the to-be-reported quarter, FOX News Channel (FNC) finished the month of February as the top-rated network in all of cable in primetime, according to Nielsen Media Research and remained the top-rated network in all of cable in primetime total viewers since inauguration.
In total day viewership, FNC delivered 1.3 million viewers for the month of February, 210K in the 25-54 age group, and 119K in the 18-49 age group, outpacing sports-focused ESPN in both dayparts with total viewership.
Further, FOX News Audio added five new podcasts to its programming catalogue, debuting each week from Mar 8.
This is expected to have helped the company reach a global audience and expand its international user base while attracting advertisers to the OTT platform, thereby generating ad revenues.
Key Development in Q3
On Mar 18, Fox Corporation announced a new and expanded media rights agreement with the National Football League (NFL) for the next 11 years through the 2033 season.
What Our Model Says
According to the Zacks model, the combination of a positive Earnings ESP and Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.
Fox has an Earnings ESP of +13.40% and a Zacks Rank #1. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks to Consider
Here are a few more companies you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat in their upcoming releases:
Playtika Holding Corp. (PLTK - Free Report) has an Earnings ESP of +18.87% and is Zacks #2 Ranked. You can see the complete list of today’s Zacks #1 Rank stocks here.
CDW Corporation (CDW - Free Report) has an Earnings ESP of +0.51% and a Zacks Rank #2.
AMETEK (AME - Free Report) has an Earnings ESP of +0.49% and a Zacks Rank #3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>